|
EP3341007B1
(en)
|
2015-08-28 |
2020-12-23 |
Cornell University |
Malt1 inhibitors and uses thereof
|
|
BR112018009511A2
(pt)
*
|
2015-11-13 |
2018-11-06 |
Novartis Ag |
derivados de pirazolo pirimidina
|
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
|
EP4491236A3
(en)
|
2016-05-10 |
2025-04-02 |
C4 Therapeutics, Inc. |
Heterocyclic degronimers for target protein degradation
|
|
WO2017197051A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Amine-linked c3-glutarimide degronimers for target protein degradation
|
|
EP3454862B1
(en)
|
2016-05-10 |
2024-09-11 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
|
EP3592731A4
(en)
*
|
2017-03-08 |
2020-10-07 |
Cornell University |
MALT1 INHIBITORS AND THEIR USES
|
|
CN118440096A
(zh)
|
2017-06-20 |
2024-08-06 |
C4医药公司 |
用于蛋白降解的n/o-连接的降解决定子和降解决定子体
|
|
CN111278816B
(zh)
|
2017-09-04 |
2024-03-15 |
C4医药公司 |
二氢喹啉酮
|
|
CN118206529A
(zh)
|
2017-09-04 |
2024-06-18 |
C4医药公司 |
二氢苯并咪唑酮
|
|
EP3679026A1
(en)
|
2017-09-04 |
2020-07-15 |
C4 Therapeutics, Inc. |
Glutarimide
|
|
CN111372585A
(zh)
|
2017-11-16 |
2020-07-03 |
C4医药公司 |
用于靶蛋白降解的降解剂和降解决定子
|
|
CA3087230A1
(en)
|
2017-12-28 |
2019-07-04 |
The General Hospital Corporation |
Targeting the cbm signalosome complex induces regulatory t cells to inflame the tumor microenvironment
|
|
WO2019191112A1
(en)
|
2018-03-26 |
2019-10-03 |
C4 Therapeutics, Inc. |
Cereblon binders for the degradation of ikaros
|
|
EP3904349B1
(en)
|
2018-04-12 |
2023-08-23 |
Bayer Aktiengesellschaft |
N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}heterocyclyl amide derivatives and similar compounds as pesticides
|
|
CN119751456A
(zh)
|
2018-04-16 |
2025-04-04 |
C4医药公司 |
螺环化合物
|
|
JP7458324B2
(ja)
|
2018-04-23 |
2024-03-29 |
セルジーン コーポレイション |
置換された４－アミノイソインドリン－１，３－ジオン化合物、及びリンパ腫の治療のためのそれらの使用
|
|
DK3784661T3
(da)
|
2018-04-25 |
2024-02-12 |
Bayer Ag |
Hidtil ukendte heteroaryl-triazol- og heteroaryl-tetrazol-forbindelser som pesticider
|
|
EP3578561A1
(en)
|
2018-06-04 |
2019-12-11 |
F. Hoffmann-La Roche AG |
Spiro compounds
|
|
CN110615779B
(zh)
*
|
2018-06-20 |
2023-03-24 |
上海科技大学 |
制备来那度胺衍生物的方法
|
|
KR102646470B1
(ko)
|
2018-11-28 |
2024-03-11 |
다케다 야쿠힌 고교 가부시키가이샤 |
헤테로시클릭 화합물
|
|
CN120698983A
(zh)
|
2018-12-20 |
2025-09-26 |
C4医药公司 |
靶向蛋白降解
|
|
WO2020191369A1
(en)
|
2019-03-21 |
2020-09-24 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
WO2020191377A1
(en)
|
2019-03-21 |
2020-09-24 |
Codiak Biosciences, Inc. |
Extracellular vesicle conjugates and uses thereof
|
|
CA3143508A1
(en)
|
2019-06-24 |
2020-12-30 |
Dana-Farber Cancer Institute, Inc. |
Hck degraders and uses thereof
|
|
KR102881314B1
(ko)
|
2019-07-23 |
2025-11-05 |
바이엘 악티엔게젤샤프트 |
살충제로서의 신규 헤테로아릴-트리아졸 화합물
|
|
UY38911A
(es)
|
2019-10-09 |
2021-05-31 |
Bayer Ag |
Compuestos de heteroarilo-triazol como pesticidas, formulaciones, usos y métodos de uso de los mismos
|
|
CA3162364A1
(en)
*
|
2019-12-20 |
2021-06-24 |
Gesine Kerstin Veits |
Protein tyrosine phosphatase degraders and methods of use thereof
|
|
CA3161339A1
(en)
*
|
2019-12-27 |
2021-07-01 |
Schrodinger, Inc. |
Cyclic compounds and methods of using same
|
|
WO2021217036A1
(en)
*
|
2020-04-23 |
2021-10-28 |
Salem Aliasger K |
Gper proteolytic targeting chimeras
|
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
|
WO2021241611A1
(ja)
|
2020-05-27 |
2021-12-02 |
武田薬品工業株式会社 |
複素環化合物の製造方法
|
|
AU2021293907A1
(en)
*
|
2020-06-17 |
2023-01-19 |
Dana-Farber Cancer Institute, Inc. |
Targeted aberrant alpha-synuclein species and induced ubiquitination and proteosomal clearance via co-recruitment of an E3-ligase system
|
|
WO2021262969A1
(en)
|
2020-06-24 |
2021-12-30 |
The General Hospital Corporation |
Materials and methods of treating cancer
|
|
WO2022066928A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
US20230414629A1
(en)
*
|
2020-11-12 |
2023-12-28 |
Monopteros Therapeutics, Inc. |
Materials and methods of treating cancer
|
|
JP2024504932A
(ja)
|
2021-01-13 |
2024-02-02 |
モンテ ローザ セラピューティクス， インコーポレイテッド |
イソインドリノン化合物
|
|
US12123053B2
(en)
|
2021-01-29 |
2024-10-22 |
Eurofins Discoverx Corporation |
Molecular glue screening assays and methods for practicing same
|
|
WO2023125877A1
(zh)
|
2021-12-30 |
2023-07-06 |
上海翰森生物医药科技有限公司 |
三并环类衍生物抑制剂、其制备方法和应用
|
|
CN118591541A
(zh)
*
|
2022-01-18 |
2024-09-03 |
奥瑞基尼肿瘤有限公司 |
作为malt-1抑制剂的经取代的双环杂环
|
|
WO2023143249A1
(zh)
*
|
2022-01-28 |
2023-08-03 |
上海齐鲁制药研究中心有限公司 |
靶向malt1的蛋白降解化合物
|
|
TW202342032A
(zh)
|
2022-02-02 |
2023-11-01 |
日商小野藥品工業股份有限公司 |
含有ｍａｌｔ１抑制劑作為有效成分的癌治療劑
|
|
EP4482497A2
(en)
*
|
2022-02-25 |
2025-01-01 |
Tegid Therapeutics, Inc. |
Protacs of malt1
|
|
AU2023283735A1
(en)
|
2022-06-06 |
2024-10-31 |
C4 Therapeutics, Inc. |
Bicyclic-substituted glutarimide cereblon binders
|